These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32335045)

  • 1. Porto-sinusoidal vascular disease. Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.
    Giudicelli H; Rautou PE; Paradis V; Bedossa P; Goria O; Lambert V; Hernandez-Gea V; Dutheil D; Plessier A; Bureau C; Valla D
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):447-451. PubMed ID: 32335045
    [No Abstract]   [Full Text] [Related]  

  • 2. Congenital portosystemic shunts: Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.
    Guérin F; Franchi Abella S; McLin V; Ackermann O; Girard M; Cervoni JP; Savale L; Hernandez-Gea V; Valla D; Hillaire S; Dutheil D; Bureau C; Gonzales E; Plessier A
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):452-459. PubMed ID: 32279979
    [No Abstract]   [Full Text] [Related]  

  • 3. Hereditary hemorrhagic telangiectasia and liver involvement: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.
    Silvain C; Thévenot T; Colle I; Vilgrain V; Dupuis-Girod S; Buscarini E; Valla D; Hillaire S; Dutheil D; Sitbon O; Bureau C; Plessier A
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):426-432. PubMed ID: 32276767
    [No Abstract]   [Full Text] [Related]  

  • 4. Pregnancy and vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.
    Payancé A; Ceccaldi PF; De Raucourt E; Valla D; Hillaire S; Dutheil D; Hernandez-Gea V; Bureau C; Plessier A
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):433-437. PubMed ID: 32278776
    [No Abstract]   [Full Text] [Related]  

  • 5. Porto-sinusoidal vascular disorder.
    De Gottardi A; Sempoux C; Berzigotti A
    J Hepatol; 2022 Oct; 77(4):1124-1135. PubMed ID: 35690264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porto-sinusoidal vascular disease: proposal and description of a novel entity.
    De Gottardi A; Rautou PE; Schouten J; Rubbia-Brandt L; Leebeek F; Trebicka J; Murad SD; Vilgrain V; Hernandez-Gea V; Nery F; Plessier A; Berzigotti A; Bioulac-Sage P; Primignani M; Semela D; Elkrief L; Bedossa P; Valla D; Garcia-Pagan JC;
    Lancet Gastroenterol Hepatol; 2019 May; 4(5):399-411. PubMed ID: 30957754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porto-sinusoidal Vascular Disease and Portal Hypertension.
    Noble S; Linz M; Correia E; Shalaby A; Bittencourt LK; Sclair SN
    Clin Liver Dis; 2024 Aug; 28(3):455-466. PubMed ID: 38945637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular liver diseases on the clinical side: definitions and diagnosis, new concepts.
    Valla DC; Cazals-Hatem D
    Virchows Arch; 2018 Jul; 473(1):3-13. PubMed ID: 29572606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for vascular liver diseases: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.
    Soret J; Debray D; Fontbrune FS; Kiladjian JJ; Saadoun D; Latour RP; Valla D; Hernandez-Gea V; Hillaire S; Dutheil D; Plessier A; Bureau C; De Raucourt E
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):410-419. PubMed ID: 32651075
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of anticoagulation in adult patients with chronic parenchymal or vascular liver disease: Vascular liver diseases: Position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.
    Ollivier-Hourmand I; Nguyen N; De Gottardi A; Valla D; Hillaire S; Dutheil D; Bureau C; Hernandez-Gea V; De Raucourt E; Plessier A
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):438-446. PubMed ID: 32278777
    [No Abstract]   [Full Text] [Related]  

  • 11. "Vascular liver diseases: Position paper(s) from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and the European Reference Network on Hepatological Diseases (ERN RARE-LIVER)".
    Plessier A; Bureau C
    Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):407-409. PubMed ID: 32360056
    [No Abstract]   [Full Text] [Related]  

  • 12. Causes and Management of Non-cirrhotic Portal Hypertension​.
    Gioia S; Nardelli S; Ridola L; Riggio O
    Curr Gastroenterol Rep; 2020 Sep; 22(12):56. PubMed ID: 32940785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic portal venopathy and related disorders of the liver.
    Chawla Y; Dhiman RK
    Semin Liver Dis; 2008 Aug; 28(3):270-81. PubMed ID: 18814080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Idiopathic Non-Cirrhotic Portal Hypertension and Porto-Sinusoidal Vascular Disease: Review of Current Data.
    Kmeid M; Liu X; Ballentine S; Lee H
    Gastroenterology Res; 2021 Apr; 14(2):49-65. PubMed ID: 34007347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatoportal sclerosis (obliterative portal venopathy) and nodular regenerative hyperplasia in a patient with myasthenia gravis: A case report and review of the published work.
    Agrawal M; Rahmani R; Nakkala K; Fiel MI; Schiano T
    Hepatol Res; 2013 Sep; 43(9):999-1003. PubMed ID: 23675894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodular regenerative hyperplasia - An under-recognized vascular disorder of liver.
    Bakshi N; Gulati N; Rastogi A; Chougule A; Bihari C; Jindal A
    Pathol Res Pract; 2020 Apr; 216(4):152833. PubMed ID: 32164988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obliterative portal venopathy without portal hypertension: an underestimated condition.
    Guido M; Sarcognato S; Sonzogni A; Lucà MG; Senzolo M; Fagiuoli S; Ferrarese A; Pizzi M; Giacomelli L; Colloredo G
    Liver Int; 2016 Mar; 36(3):454-60. PubMed ID: 26264219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
    Abraham SC; Kamath PS; Eghtesad B; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2006 Nov; 30(11):1454-61. PubMed ID: 17063088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of hepatic vascular diseases.
    Plessier A; Rautou PE; Valla DC
    J Hepatol; 2012; 56 Suppl 1():S25-38. PubMed ID: 22300463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular diseases of the liver. Clinical Guidelines from the Catalan Society of Digestology and the Spanish Association for the Study of the Liver.
    Martín-Llahí M; Albillos A; Bañares R; Berzigotti A; García-Criado MÁ; Genescà J; Hernández-Gea V; Llop-Herrera E; Masnou-Ridaura H; Mateo J; Navascués CA; Puente Á; Romero-Gutiérrez M; Simón-Talero M; Téllez L; Turon F; Villanueva C; Zarrabeitia R; García-Pagán JC
    Gastroenterol Hepatol; 2017 Oct; 40(8):538-580. PubMed ID: 28610817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.